pharmacist patient education and counseling
TRANSCRIPT
![Page 1: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/1.jpg)
Patient Educationand Counseling
Prepared by : Dr.Hemat Afifi Sherif
![Page 2: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/2.jpg)
Introduction
![Page 3: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/3.jpg)
Lack of sufficient knowledge about their health
problems and medications
one cause of patients’ non-adherence to their
pharmaco-therapeutic regimens and monitoring
plans
Improve patient adherence Reduce medication-related problems.
knowledge skills
![Page 4: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/4.jpg)
Educating Counseling
CaregiversIndividual
Patients
Patient
Groups
Families
![Page 5: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/5.jpg)
Educating Counseling
preventative in nature.
It foresees the potential
problems
prepares the learner ahead
of time with possible
scenarios and solutions to
those problems.
It has more to do with
the now, why, and how of
things.
It can be given in a formal
setting among a group or
individually as the need
requires.
After the fact.
It is the reaction to
occurrences and
negative situations that
need to be corrected,
altered, or changed.
It is given more on an
individual basis and in a private setting
![Page 6: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/6.jpg)
knowledge
patients’ cultures
Health and illness
beliefs
Attitudes Practices.
patients’ feelings
Toward the health
system
Views of their own roles
and responsibilities for
decision-making and for
managing their care
![Page 7: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/7.jpg)
Assessing a patient’s
Cognitive abilities
Learning style
Sensory and physical status
Whether patients know how to use their
medications
whether a patient is willing to use a medication
![Page 8: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/8.jpg)
A patient may be unable
to hear oral instructions
may lack sufficient motor
skills to open a child-
resistant container.
A patient may lack the
visual acuity to read labels
on prescription containers,
markings on syringes, or
written handout material.
![Page 9: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/9.jpg)
skills
1. Effective, open-ended questioning
2. Active listening
3. Adapt messages to fit patients’ language skills
4. Observe and interpret the nonverbal messages e.g.
Eye contact
Facial expressions
Body movements
Vocal characteristics
![Page 10: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/10.jpg)
1. Comfortable
2. Confidential3. Safe
In a room or space that ensures privacy and
opportunity to engage in confidential
communication.
Environment
common area can be restructured to maximize
visual and auditory privacy from other patients
or staff.
Patients, including those who are disabled, should
have easy access and seating.
![Page 11: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/11.jpg)
Space and seating should be adequate for family
members or caregivers
The design and placement of desks and counters
should minimize barriers to communication.
Distractions and
interruptions should
be few, so that
patients and
pharmacists can
have each other’s
undivided attention.
![Page 12: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/12.jpg)
The environment should be equipped with
appropriate learning aids e.G.
Graphics
Anatomical models
Medication administration devices
Memory aids
Written material
Audiovisual resources.
![Page 13: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/13.jpg)
To determine what specific information and
counseling are required in each patient care
situation.
Collaboration With Other Health Care
Team
![Page 14: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/14.jpg)
Home care
Patient Education And Counseling
Guidelines Are Applicable In All Practice
Settings—including
Acute inpatient care
Long-term care
Ambulatory care
![Page 15: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/15.jpg)
Patient education and counseling usually occur:
at the time prescriptions are dispensed
but may also be provided as a separate service.
Education Time
![Page 16: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/16.jpg)
Pharmacist and
Patient Roles
![Page 17: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/17.jpg)
assess that The patients have
sufficient:
understanding
Knowledge
skill
to follow their pharmaco-
therapeutic regimens and
monitoring plans.
seek ways to motivate
patients to:
learn about their
treatment
be active partners in
their care.
Pharmacist Roles
![Page 18: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/18.jpg)
pharmacists may also have disease management roles
and responsibilities for specified categories of patients
Depending on:
The health system’s policies and procedures
Its use of protocols or clinical care plans
![Page 19: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/19.jpg)
Patient Roles
Adhere to their pharmaco-therapeutic regimens
Monitor for drug effects
Report their experiences to pharmacists or other
members of their health care teams.
seeking information
and presenting
concerns that may
make adherence
difficult.
![Page 20: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/20.jpg)
Process
Steps
![Page 21: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/21.jpg)
Introduce yourself as a pharmacist
Explain the purpose and expected length of
the sessions
Obtain the patient’s agreement to
participate
1
Assess the patient’s:
Knowledge about his or her health
problems and medications
Physical and mental capability to use the
medications appropriately
Attitude toward the health problems and
medications
2
![Page 22: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/22.jpg)
Ask open-ended questions about each
medication’s purpose and what the
patient expects
Ask the patient to describe or show how
he or she will use the medication
They should also be asked to describe
any problems, concerns, or
uncertainties they are experiencing with
their medications
3
![Page 23: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/23.jpg)
Provide information orally and use visual aids
or demonstrations to fill patients’ gaps in
knowledge and understanding
4
Open the medication containers to show
patients the colors, sizes, shapes, and
markings on oral solids.
![Page 24: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/24.jpg)
Demonstrate the assembly and use of
administration devices such as nasal and oral
inhalers.
For oral liquids and
injectable, show patients the
dosage marks on measuring
devices.
![Page 25: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/25.jpg)
As a supplement
to face-to-face oral
communication,
provide written
handouts to help
the patient recall
the information.
![Page 26: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/26.jpg)
Then adjust the pharmacotherapeutic regimens
according to protocols or notify the
prescribers.
If a patient is experiencing problems with his or
her medications, gather appropriate data and
assess the problems.
![Page 27: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/27.jpg)
Verify patients’ knowledge and understanding of
medication use
5
Ask patients to describe or show how they will
use their medications and identify their effects
Observe patients’ medication-use capability and
accuracy and attitudes toward following their
pharmaco-therapeutic regimens and monitoring
plans.
![Page 28: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/28.jpg)
Content
![Page 29: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/29.jpg)
1
The medication’s trade name
generic name
common or other descriptive name(s)
when appropriate
its therapeutic class and efficacy.
The medication’s use and expected benefits and
action.
whether the medication is intended to :
cure a disease, eliminate or reduce symptoms
arrest or slow the disease process, or prevent
the disease or a symptom.
2
![Page 30: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/30.jpg)
The medication’s route
dosage form
Dosage
administration schedule (including duration of
therapy).
3
4
The medication’s expected onset of action and
what to do if the action does not occur.
![Page 31: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/31.jpg)
Directions for preparing and using or
administering the medication.
This may include adaptation to fit patients’
lifestyles or work environments
Action to be taken in case of a missed dose.
6
5
![Page 32: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/32.jpg)
Precautions to be observed during the
medication’s use or administration
The medication’s potential risks in relation to
benefits.
For injectable medications and administration
devices, concern about allergy may be discussed.
7
![Page 33: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/33.jpg)
Techniques for self-monitoring of the
pharmacotherapy.
Potential common and severe adverse effects
that may occur
actions to prevent or minimize their
occurrence
actions to take if they occur
including notifying the prescriber, pharmacist,
or other health care provider.
8
9
![Page 34: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/34.jpg)
Potential drug–drug (including nonprescription)
Drug–food
Drug–disease interactions
Contraindications.
10
The medication’s relationships to radiologic
and laboratory procedures
(e.g., timing of doses and potential interferences
with interpretation of results).
11
![Page 35: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/35.jpg)
Proper storage of the medication.
12
Proper disposal of contaminated or discontinued
medications and used administration devices
13
14
Any other information unique to an individual
patient or medication
![Page 36: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/36.jpg)
Additional content may be appropriate when
pharmacists have authorized responsibilities in
collaborative disease management for
specified categories of patients.
These points are applicable to both
prescription and nonprescription medications.
Pharmacists should counsel patients in the
proper selection of nonprescription
medications.
![Page 37: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/37.jpg)
3. Recognition and monitoring of disease
complications.
Depending on the patient’s disease management
or clinical care plan, the following may be
covered:
1. The disease state:
whether it is acute or chronic
its prevention, transmission, progression, and
recurrence.
2. Expected effects of the disease on the patient’s
normal daily living.
![Page 38: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/38.jpg)
Documentation
![Page 39: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/39.jpg)
Pharmacists should document education and
counseling in patients’ permanent medical
records as consistent with:
the patients’ care plans
the health system’s policies and procedures
![Page 40: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/40.jpg)
Education and counseling may be
documented
When pharmacists do not have access to
patients’ medical records
1. In the pharmacy’s patient profiles
2. On the medication order or prescription
form
3. On a specially designed counseling
record.
![Page 41: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/41.jpg)
All documentation should be safeguarded to respect patient confidentiality and privacy
The Pharmacist Should Record
That counseling was
offered and was
accepted and provided or refused
The pharmacist’s
perceived level of the
patient’s
understanding
As appropriate, the content should be
documented (for example, counseling about
food–drug interactions).
![Page 42: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/42.jpg)
![Page 43: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/43.jpg)
![Page 44: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/44.jpg)
![Page 45: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/45.jpg)
![Page 46: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/46.jpg)
![Page 47: pharmacist patient education and counseling](https://reader031.vdocuments.us/reader031/viewer/2022021422/5a6578127f8b9af13a8b4b23/html5/thumbnails/47.jpg)
Thank you
ASHP Guidelines
on Pharmacist-Conducted
Patient Education and Counseling
Reference